JP2020510816A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020510816A5 JP2020510816A5 JP2019542716A JP2019542716A JP2020510816A5 JP 2020510816 A5 JP2020510816 A5 JP 2020510816A5 JP 2019542716 A JP2019542716 A JP 2019542716A JP 2019542716 A JP2019542716 A JP 2019542716A JP 2020510816 A5 JP2020510816 A5 JP 2020510816A5
- Authority
- JP
- Japan
- Prior art keywords
- sftbp
- cyfra21
- pro
- cea
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 18
- 102100022019 Pregnancy-specific beta-1-glycoprotein 2 Human genes 0.000 claims 12
- 108010036226 antigen CYFRA21.1 Proteins 0.000 claims 12
- NQNXERHVLXYXRO-UHFFFAOYSA-N Diacetylspermine Chemical compound Cl.Cl.CC(=O)NCCCNCCCCNCCCNC(C)=O NQNXERHVLXYXRO-UHFFFAOYSA-N 0.000 claims 10
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 8
- 239000012472 biological sample Substances 0.000 claims 8
- 201000005202 lung cancer Diseases 0.000 claims 8
- 208000020816 lung neoplasm Diseases 0.000 claims 8
- 239000000427 antigen Substances 0.000 claims 7
- 102000036639 antigens Human genes 0.000 claims 7
- 108091007433 antigens Proteins 0.000 claims 7
- 238000005481 NMR spectroscopy Methods 0.000 claims 3
- 239000000090 biomarker Substances 0.000 claims 3
- 238000005016 nuclear Overhauser enhanced spectroscopy Methods 0.000 claims 3
- 108010008629 CA-125 Antigen Proteins 0.000 claims 2
- 102000007269 CA-125 Antigen Human genes 0.000 claims 2
- 238000005100 correlation spectroscopy Methods 0.000 claims 2
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 claims 2
- 238000004949 mass spectrometry Methods 0.000 claims 2
- 230000035945 sensitivity Effects 0.000 claims 2
- 238000004611 spectroscopical analysis Methods 0.000 claims 2
- 238000005160 1H NMR spectroscopy Methods 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 208000009956 adenocarcinoma Diseases 0.000 claims 1
- 238000003556 assay Methods 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 210000002381 plasma Anatomy 0.000 claims 1
- 239000000523 sample Substances 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 206010041823 squamous cell carcinoma Diseases 0.000 claims 1
- 238000013179 statistical model Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762456731P | 2017-02-09 | 2017-02-09 | |
| US62/456,731 | 2017-02-09 | ||
| PCT/US2018/017704 WO2018148600A1 (en) | 2017-02-09 | 2018-02-09 | Methods for the detection and treatment of lung cancer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020510816A JP2020510816A (ja) | 2020-04-09 |
| JP2020510816A5 true JP2020510816A5 (enExample) | 2021-03-25 |
| JP7311417B2 JP7311417B2 (ja) | 2023-07-19 |
Family
ID=63107741
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019542716A Active JP7311417B2 (ja) | 2017-02-09 | 2018-02-09 | 肺癌の検出および処置のための方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US12405274B2 (enExample) |
| EP (2) | EP4528741A3 (enExample) |
| JP (1) | JP7311417B2 (enExample) |
| KR (2) | KR102827354B1 (enExample) |
| CN (2) | CN110291397A (enExample) |
| CA (1) | CA3053116A1 (enExample) |
| ES (1) | ES2995959T3 (enExample) |
| WO (1) | WO2018148600A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110291397A (zh) | 2017-02-09 | 2019-09-27 | 得克萨斯大学体系董事会 | 肺癌的检测和治疗方法 |
| CA3146120A1 (en) * | 2019-07-29 | 2021-02-04 | Rashid BUX | Method of discriminating lung cancer patients |
| CA3181609A1 (en) * | 2020-04-28 | 2021-11-04 | Luxembourg Institute Of Health (Lih) | Biomarkers for detection of lung cancer |
| WO2022051753A1 (en) * | 2020-09-01 | 2022-03-10 | Oncodea Corporation | Predictive diagnostic test for early detection and monitoring of diseases |
| CN112147099A (zh) * | 2020-09-22 | 2020-12-29 | 范庆坤 | 一种m蛋白紫外分光检测法 |
| WO2022072471A1 (en) * | 2020-10-02 | 2022-04-07 | Board Of Regents, The University Of Texas System | Methods for the detection and treatment of lung cancer |
| EP4357782A1 (en) * | 2022-10-18 | 2024-04-24 | MU Bioteknik Aktiebolag | Protein biomarker panel for the diagnosis of colorectal cancer |
| CN115575636B (zh) * | 2022-11-22 | 2023-04-04 | 杭州广科安德生物科技有限公司 | 一种用于肺癌检测的生物标志物及其系统 |
| CN116593702B (zh) * | 2023-05-11 | 2024-04-05 | 杭州广科安德生物科技有限公司 | 一种肺癌的生物标志物以及诊断系统 |
| CN118983078B (zh) * | 2024-08-15 | 2025-03-25 | 立本医疗器械(成都)有限公司 | 基于ptr-tof-ms的肺癌筛查模型构建方法 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2606015T3 (es) * | 2005-12-22 | 2017-03-17 | Abbott Molecular Inc. | Métodos y combinaciones de marcadores para la detección de la predisposición al cáncer de pulmón |
| US20080133141A1 (en) * | 2005-12-22 | 2008-06-05 | Frost Stephen J | Weighted Scoring Methods and Use Thereof in Screening |
| EP2515116A1 (en) * | 2007-05-18 | 2012-10-24 | Duke University | Serum biomarkers for the early detection of lung cancer |
| JP2013525814A (ja) * | 2010-05-07 | 2013-06-20 | アッヴィ・インコーポレイテッド | 標的化チロシンキナーゼインヒビターでの治療に対する感受性の予測方法 |
| US20120093733A1 (en) * | 2010-05-24 | 2012-04-19 | Marek Malecki | Multidomain biotags for cancer detection, diagnosis and therapy and methods of their use |
| WO2011150974A1 (en) | 2010-06-03 | 2011-12-08 | Porto Conte Ricerche S.R.L. | Biomarkers for lung neuroendocrine tumors |
| CN102321760A (zh) * | 2011-08-26 | 2012-01-18 | 泸州医学院附属医院 | 一种非小细胞肺癌标志物及应用 |
| US9753043B2 (en) * | 2011-12-18 | 2017-09-05 | 20/20 Genesystems, Inc. | Methods and algorithms for aiding in the detection of cancer |
| US20140271453A1 (en) * | 2013-03-14 | 2014-09-18 | Abbott Laboratories | Methods for the early detection of lung cancer |
| US9753037B2 (en) * | 2013-03-15 | 2017-09-05 | Rush University Medical Center | Biomarker panel for detecting lung cancer |
| US20150072890A1 (en) * | 2013-09-11 | 2015-03-12 | 20/20 Gene Systems, Inc. | Methods and compositions for aiding in the detection of lung cancer |
| US20160060329A1 (en) * | 2014-07-28 | 2016-03-03 | Donald SIN | Compositions and methods for the diagnosis and prognosis of lung cancer |
| CN108139381A (zh) | 2015-06-26 | 2018-06-08 | 百奥马克癌症系统公司 | 肺癌检测方法 |
| JP6903672B2 (ja) | 2016-03-08 | 2021-07-14 | マグアレイ，インコーポレイテッド | 肺癌の診断および治療のための蛋白質と自己抗体バイオマーカー |
| CN105717146B (zh) * | 2016-03-29 | 2018-11-09 | 复旦大学附属中山医院 | 一种基于ct影像及生物标志物谱针对中国城市人口高危人群的肺癌风险预测试剂盒 |
| CN110291397A (zh) | 2017-02-09 | 2019-09-27 | 得克萨斯大学体系董事会 | 肺癌的检测和治疗方法 |
| WO2022072471A1 (en) * | 2020-10-02 | 2022-04-07 | Board Of Regents, The University Of Texas System | Methods for the detection and treatment of lung cancer |
-
2018
- 2018-02-09 CN CN201880010925.0A patent/CN110291397A/zh active Pending
- 2018-02-09 KR KR1020247002923A patent/KR102827354B1/ko active Active
- 2018-02-09 CN CN202311117176.0A patent/CN117368475A/zh active Pending
- 2018-02-09 JP JP2019542716A patent/JP7311417B2/ja active Active
- 2018-02-09 WO PCT/US2018/017704 patent/WO2018148600A1/en not_active Ceased
- 2018-02-09 EP EP24204031.9A patent/EP4528741A3/en active Pending
- 2018-02-09 KR KR1020197026040A patent/KR102630885B1/ko active Active
- 2018-02-09 ES ES18752036T patent/ES2995959T3/es active Active
- 2018-02-09 EP EP18752036.6A patent/EP3580560B1/en active Active
- 2018-02-09 CA CA3053116A patent/CA3053116A1/en active Pending
-
2023
- 2023-03-28 US US18/191,506 patent/US12405274B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020510816A5 (enExample) | ||
| Park et al. | An integrated magneto-electrochemical device for the rapid profiling of tumour extracellular vesicles from blood plasma | |
| Wei et al. | Plasma extracellular vesicles detected by Single Molecule array technology as a liquid biopsy for colorectal cancer | |
| Jenkinson et al. | Decreased serum thrombospondin-1 levels in pancreatic cancer patients up to 24 months prior to clinical diagnosis: association with diabetes mellitus | |
| Fung et al. | Classification of cancer types by measuring variants of host response proteins using SELDI serum assays | |
| Wang et al. | Investigation and identification of potential biomarkers in human saliva for the early diagnosis of oral squamous cell carcinoma | |
| US8653006B2 (en) | Metabolite biomarkers for the detection of esophageal cancer using NMR | |
| JPWO2016163539A1 (ja) | 肝疾患の病態を判別する方法 | |
| JP2020514689A5 (enExample) | ||
| JP7179356B2 (ja) | 代謝物分析を利用したベーチェット病の診断方法 | |
| EP3775906A1 (en) | Metabolite-based breast cancer detection and diagnosis | |
| Yi et al. | Metabolomic identification of novel biomarkers of nasopharyngeal carcinoma | |
| Sahni et al. | A unique urinary metabolomic signature for the detection of pancreatic ductal adenocarcinoma | |
| CN113791219A (zh) | 用于急性缺血性脑卒中复发风险分析的生物标志物及其应用 | |
| Stenson et al. | Serum nuclear magnetic resonance-based metabolomics and outcome in diffuse large B-cell lymphoma patients–a pilot study | |
| Krishnan et al. | Circulating metabolite biomarkers: a game changer in the human prostate cancer diagnosis | |
| Liang et al. | Lipidomics analysis based on liquid chromatography mass spectrometry for hepatocellular carcinoma and intrahepatic cholangiocarcinoma | |
| Gîrleanu et al. | Platelet indices in patients with de novo portal vein thrombosis and liver cirrhosis | |
| Timms et al. | Peptides generated ex vivo from serum proteins by tumor-specific exopeptidases are not useful biomarkers in ovarian cancer | |
| JPWO2022072471A5 (enExample) | ||
| CN115684451A (zh) | 基于代谢组学的食管鳞癌淋巴结转移诊断标志物及其应用 | |
| Kohli et al. | Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) for determining prognosis in advanced stage hormone relapsing prostate cancer | |
| Fan et al. | Serum Peptidome Patterns of Colorectal Cancer Based on Magnetic Bead Separation and MALDI‐TOF Mass Spectrometry Analysis | |
| KR20230113742A (ko) | 난소암의 검출 및 치료를 위한 방법 | |
| CN118658612A (zh) | 一种基于外泌体蛋白标志物的肺癌辅助诊断和预后评估的系统 |